E
Zentalis Pharmaceuticals, Inc. ZNTL
$1.77 -$0.04-2.21%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 37.37% 31.73% 9.15% -23.39% -23.44%
Total Depreciation and Amortization -7.23% -7.09% -6.17% -2.59% 10.58%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -93.29% -82.41% -79.02% 32.10% 45.43%
Change in Net Operating Assets 290.97% 189.93% -151.35% -55.75% -103.60%
Cash from Operations 16.03% 16.43% -29.28% -26.91% -25.15%
Capital Expenditure 30.88% 77.33% 70.31% 77.12% 87.55%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 847.32% -150.32% 72.80% 60.70% 74.79%
Cash from Investing 815.21% -151.53% 72.75% 61.06% 75.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.88% -99.80% -8.83% -9.09% 27.74%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -99.96% -99.89% -8.93% -9.09% 28.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -201.80% -208.57% -74.57% 11.32% 6,060.79%
Weiss Ratings